Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What signals matter most for Perimeter PMTRU stock The one question every Royal Bank RY investor should ask 015 20260508 SLF Sun Life Q1 2026 EPS narrowly misses consensus estimates shares dip 015 following results GGRP The reports wider than expected Q1 2026 per share loss stock dips modestly post earnings Morgan Stanley Adjusts Edison International Price Target Amid April Utility Sector Review OpenAI IPO Filing Could Signal New Era for AI Companies in Public Markets Berkshire Hathaway Reenters Airlines with 26 Billion Delta Air Lines Stake Wiliot and ATT Business Partner to Accelerate Physical AI in Global Supply Chains PepsiCo Plans New Snack Price Increases for Late June Bloomberg Reports US Consumer Sentiment Remains Depressed Inflation Geopolitical Tensions and Trade Policy Weigh on Americans Outlook SHW Q1 2026 Earnings EPS Beats Estimates but Stock Slips Slightly XWEL Q3 2023 Earnings Significant EPS Miss with No Reported Revenue PINS Q1 2026 Earnings EPS Beat Drives Modest Stock Gains STSS Q3 2025 Earnings EPS Misses Estimates by a Wide Margin as Revenue Remains Unreported PDS Biotechnology Q1 2026 Earnings EPS Beat and Clinical Progress Highlight PreRevenue Quarter MNSBP Q1 2026 Earnings EPS Surges Past Estimates by 242 Tanger Inc SKT Faces Selling Pressure as Stock Dips Toward Key Support Silexion Therapeutics Warrants SLXNW Hold Steady at 002 Amid Thin Trading Apimeds Pharmaceuticals APUS Slides 423 Support Level in Focus Brinks Company BCO Holds Steady Near 105 Amid Tight Trading Range Berto Acquisition Corp Unit TACOU Climbs 3 as Price Nears 1165 Resistance MSCI Q1 2026 Earnings EPS Beats Estimates Shares Edge Higher CSAN Q1 2026 Earnings Heavy Losses as EPS Misses Estimates by a Wide Margin HOVR Q1 2026 Earnings EPS Misses Estimates as PreRevenue Company Focuses on Development ENDRA Life Sciences Q1 2026 Earnings EPS Misses Estimates as Development Continues CAPL Q1 2026 Earnings Strong EPS Surprise Despite Challenging Environment Pulmatrix Q2 2025 Earnings Loss Per Share Widens Amidst No Revenue Disclosure